Berna ÖZYAZGAN, Müslüm AKGÖZ, Yılmaz ÇİĞREMİŞ

Caveolin-1 gene expression in rats model of chronic renal failure

In this study, gene expression profile of caveoline and the kidney MDA and BUN and creatinine levels were investigated in experimentally renal failure case of rats. In the experimental group, rats were injected with 30 mg/kg of cyclosporin A via subcutaneous route for 28 days. In the control group, rats were injected with cremophor EL, vehicle for cyclosporin A, for 28 days. Caveolin gene analysis and MDA analysis in the kidney tissue as well as serum BUN and creatinine analysis were performed at the end of the experiment. Caveolin gene expression of experimental group was significantly reduced (P < 0.05), while the MDA level was significantly increased compared to those of control (P < 0.05). Serum BUN and creatinine levels were significantly increased in the experimental group compared to the control group (P < 0.05). In the Cyclosporin A induced chronic renal failure model, we suggest that the induction of the Cav-1 gene expression may prevent the renal tissue damage

PDF

___

1. Haynes RJ, Winearls CG. Chronic kidney disease. Surgery (Oxford). 2010;28:525-9.

2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, AS L. Prevalence of chronic kidney disease in the united states. JAMA. 2007;298(17):2038-47.

3. Gentille Lorente D, Gentille Lorente J, Salvadó Usach T. Repeated serum creatinine measurement in primary care: Not all patients have chronic renal failure. Nefrología. 2015;35(4):395-402.

4. Deegan BF, Richard RD, Bowen TR, Perkins RM, Graham JH, Foltzer MA. Impact of chronic kidney disease stage on lowerextremity arthroplasty. Orthopedics. 2014;37(7):e613-8.

5. Le Lay S, Kurzchalia TV. Getting rid of caveolins: Phenotypes of caveolin-deficient animals. Biochim Biophys Acta. 2005;1746(3):322-33.

6. van Meer G, Burger KN. Sphingolipid trafficking--sorted out? Trends Cell Biol. 1992;2(11):332-7.

7. van Meer G, Stelzer EH, Wijnaendts-van-Resandt RW, Simons K. Sorting of sphingolipids in epithelial (madin-darby canine kidney) cells. J Cell Biol. 1987;105(4):1623-35.

8. Burgermeister E, Liscovitch M, Rocken C, Schmid RM, Ebert MP. Caveats of caveolin-1 in cancer progression. Cancer Lett. 2008;268(2):187-201.

9. Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Differential expression of caveolin-1 in renal neoplasms. Cancer. 2007;110(4):776-82.

10. Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathol. 2006;125(3):392-8.

11. Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem. 2002;277(12):10661-8.

12. Taugner R, Buhrle CP, Nobiling R. Ultrastructural changes associated with renin secretion from the juxtaglomerular apparatus of mice. Cell Tissue Res. 1984;237(3):459-72.

13. Andoh TF, Lam TT, Lindsley J, Alpers CE, Bennett WM. Enhancement of chronic cyclosporine nephrotoxicity by sodium depletion in an experimental mouse model. Nephrology. 1997;3:471- 8.

14. Al-Amran FG, Hadi NR, Kamoona TH, Kadhum ZJ. Amelioration of chronic cyclosporine a-induced nephrotoxicity by telmisartan in rats. Afr J Pharm Pharmacol. 2011;5(4):500-5.

15. Yang NH, Ying CJ, Xu MJ, Zuo XZ, Ye XL, Liu LG, Nara YS, Sun XF. High-fat diet up-regulates caveolin-1 expression in aorta of dietinduced obese but not in diet-resistant rats. Cardiovasc Res. 2007;76(1):167-74.

16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2(t)(-delta delta c) method. Methods. 2001;25(49:402-8.

17. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271- 8.

18. Bai Y, Ye S, Mortazavi R, Campese V, Vaziri ND. Effect of renal injury-induced neurogenic hypertension on no synthase, caveolin-1, akt, calmodulin and soluble guanylate cyclase expressions in the kidney. Am J Physiol Renal Physiol. 2007;292(3):F974-80.

19. Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. P42/44 map kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of ras-map kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J Biol Chem. 1999;274(45):32333-41.

20. Yang XY, Huang CC, Kan QM, Li Y, Liu D, Zhang XC, Sato T, Yamagata S, Yamagata T. Calcium regulates caveolin-1 expression at the transcriptional level. Biochem Bioph Res Co. 2012;426(3):334- 41.

21. Fakhrzadeh L, Laskin JD, Laskin DL. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation. Toxicol Appl Pharmacol. 2008;227(3):380-9.

22. Diederich D, Skopec J, Diederich A, Dai FX. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension. 1994;23(6 Pt2):957-61.

23. Sener G, Paskaloglu K, Satiroglu H, Alican I, Kacmaz A, Sakarcan A. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol. 2004;43(5):698-705.

24. Rezzani R. Cyclosporine a and adverse effects on organs: Histochemical studies. Prog Histochem Cytochem. 2004;39(2):85- 128.

25. Inselmann G, Baumann K. Effect of cyclosporine a on accumulation of tetraethylammonium and p-aminohippurate, and on lipid peroxidation in rat renal microsomes and cortical slices. Ren Fail. 1990;12(3):165-9.

26. Couet J, Belanger MM, Roussel E, Drolet MC. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev. 2001;49(3):223-35.

27. Garcia IM, Mazzei L, Benardon ME, Oliveros L, Cuello-Carrion FD, Gil Lorenzo A, Manucha W, Valles PG. Caveolin-1-enos/hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy. Nitric Oxide. 2012;27(2):95-105.